Prelude Therapeutics Incorporated
No trades
Price target
3.500.000.00%
The 2 analysts offering 1-year price forecasts have a max estimate of — and a min estimate of —.
Analyst rating
Based on 2 analysts giving stock ratings in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
PRLD EPS for the last quarter is −0.26 USD despite the estimation of −0.37 USD. In the next quarter EPS is expected to reach −0.03 USD. Track more of Prelude Therapeutics Incorporated financials and stay on top of what is up with the company.
In the next quarter Prelude Therapeutics Incorporated revenue is expected to reach 20.50 M USD. Check out Prelude Therapeutics Incorporated revenue and earnings and make informed decisions.
According to analysts, PRLD price target is 3.50 USD with a max estimate of 4.00 USD and a min estimate of 3.00 USD. Check if this forecast comes true in a year, meanwhile watch Prelude Therapeutics Incorporated stock price chart and keep track of the current situation with PRLD news and stock market news.